Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St. Jude Builds Chronic Pain Business With NeuroTherm Acquisition

This article was originally published in The Gray Sheet

Executive Summary

NeuroTherm makes devices for radiofrequency ablation of nerves in painful facet joints in the neck or back to treat chronic pain. Although it markets neurostimulators, St. Jude currently does not sell any devices in the radio-frequency ablation segment of the pain-therapy market.

You may also be interested in...



St. Jude Warning Letter Spotlights CAPA Flaws At CardioMEMS Unit

The warning letter highlights validation and recordkeeping problems at the Atlanta manufacturing facility for the CardioMEMS heart failure remote monitoring system, but it is not expected to affect device availability.

St. Jude Medical Receives CE Mark For Prodigy Neurostimulation System

In March, St. Jude Medica received CE mark for its Prodigy Chronic Pain System with Burst Technology. According to the company, Prodigy is the only spinal cord stimulation device on the market that offers both tonic and burst stimulation to patients suffering from chronic pain.

Neuromodulation Market: Innovation Brings High-Growth Rewards

Related Companies

Related Deals

Latest News
See All
UsernamePublicRestriction

Register

MT033163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel